Skip to content

US · TAOX

TAO Synergies Inc.

Sector
Healthcare · Biotechnology
Headquarters
New York, NY 10036

Price · as of 2026-09-04

$3.89

Market cap 26.08M

Price history

Weekly OHLC price history for TAOX, USD per share
WeekOpenHighLowCloseVolume
Jun 23, 2025 – Jun 27, 2025$3.51$6.19$3.50$6.050
Jun 30, 2025 – Jul 3, 2025$6.39$8.94$5.63$8.500
Jul 7, 2025 – Jul 11, 2025$8.48$9.00$6.96$8.990
Jul 14, 2025 – Jul 18, 2025$9.03$11.98$8.56$10.110
Jul 21, 2025 – Jul 25, 2025$10.05$10.70$7.81$8.410
Jul 28, 2025 – Aug 1, 2025$8.82$8.82$5.70$5.990
Aug 4, 2025 – Aug 8, 2025$5.87$6.70$5.50$6.160
Aug 11, 2025 – Aug 15, 2025$6.25$9.75$6.18$8.400
Aug 18, 2025 – Aug 22, 2025$8.10$8.73$6.39$7.650
Aug 25, 2025 – Aug 29, 2025$7.51$7.61$5.60$5.820
Sep 1, 2025 – Sep 5, 2025$5.74$6.50$5.57$6.190
Sep 8, 2025 – Sep 12, 2025$6.25$6.83$5.74$6.210
Sep 15, 2025 – Sep 19, 2025$6.14$7.00$5.60$5.830
Sep 22, 2025 – Sep 26, 2025$5.85$6.20$5.25$5.850
Sep 29, 2025 – Oct 3, 2025$6.10$7.57$5.91$6.410
Oct 6, 2025 – Oct 10, 2025$6.50$8.14$6.50$6.890
Oct 13, 2025 – Oct 17, 2025$7.88$10.00$6.88$7.230
Oct 20, 2025 – Oct 24, 2025$7.94$9.40$7.22$8.620
Oct 27, 2025 – Oct 31, 2025$8.92$9.43$7.46$8.760
Nov 3, 2025 – Nov 7, 2025$8.50$8.74$6.97$8.320
Nov 10, 2025 – Nov 14, 2025$8.48$8.77$6.19$6.600
Nov 17, 2025 – Nov 21, 2025$6.00$7.22$5.60$6.400
Nov 24, 2025 – Nov 28, 2025$6.65$7.85$6.56$7.580
Dec 1, 2025 – Dec 5, 2025$7.16$7.21$5.80$5.990
Dec 8, 2025 – Dec 12, 2025$6.16$6.77$5.90$6.020
Dec 15, 2025 – Dec 19, 2025$6.09$6.19$4.67$5.030
Dec 22, 2025 – Dec 26, 2025$5.03$5.21$4.29$4.290
Dec 29, 2025 – Jan 2, 2026$4.28$4.50$3.53$4.430
Jan 5, 2026 – Jan 9, 2026$4.78$5.60$4.64$5.060
Jan 12, 2026 – Jan 16, 2026$5.08$5.91$5.08$5.370
Jan 19, 2026 – Jan 23, 2026$5.24$5.47$4.52$4.580
Jan 26, 2026 – Jan 30, 2026$4.51$5.33$4.18$4.270
Feb 2, 2026 – Feb 6, 2026$4.25$4.48$3.31$3.960
Feb 9, 2026 – Feb 13, 2026$3.90$4.15$3.50$3.940
Feb 16, 2026 – Feb 20, 2026$4.14$4.34$3.60$3.900
Feb 23, 2026 – Feb 27, 2026$3.95$4.66$3.68$3.910
Mar 2, 2026 – Mar 6, 2026$3.74$4.77$3.74$3.970
Mar 9, 2026 – Mar 13, 2026$4.00$6.40$4.00$5.640
Mar 16, 2026 – Mar 20, 2026$5.99$6.50$5.04$5.950
Mar 23, 2026 – Mar 27, 2026$5.95$7.15$5.06$5.220
Mar 30, 2026 – Apr 2, 2026$5.24$6.01$5.00$5.700
Apr 6, 2026 – Apr 10, 2026$5.63$6.25$3.78$4.290
Apr 13, 2026 – Apr 17, 2026$4.14$4.99$4.11$4.970
Apr 20, 2026 – Apr 24, 2026$4.83$5.49$4.65$5.190
Apr 27, 2026 – May 1, 2026$5.20$5.45$4.77$5.330
May 4, 2026 – May 8, 2026$5.38$6.86$5.33$6.480
May 11, 2026 – May 15, 2026$6.43$6.90$5.02$5.220
May 18, 2026 – May 22, 2026$5.03$5.28$4.26$4.530
May 25, 2026 – May 29, 2026$4.60$4.75$4.00$4.200
Jun 1, 2026 – Jun 5, 2026$4.16$4.30$3.63$3.810
Jun 8, 2026 – Jun 12, 2026$3.98$4.07$3.50$3.620
Jun 15, 2026 – Jun 18, 2026$4.04$4.23$3.62$3.670
Jun 22, 2026 – Jun 26, 2026$3.66$3.82$3.30$3.580
Jun 29, 2026 – Jul 2, 2026$3.58$4.00$3.47$3.660
Jul 6, 2026 – Jul 10, 2026$3.69$3.90$3.47$3.790
Jul 13, 2026 – Jul 17, 2026$3.78$4.19$3.22$3.460
Jul 20, 2026 – Jul 24, 2026$3.46$3.94$3.29$3.290
Jul 27, 2026 – Jul 31, 2026$3.33$3.64$3.18$3.290
Aug 3, 2026 – Aug 7, 2026$3.41$3.89$3.34$3.370
Aug 10, 2026 – Aug 14, 2026$3.37$3.75$3.37$3.440
Aug 17, 2026 – Aug 21, 2026$3.40$4.25$3.07$3.860
Aug 24, 2026 – Aug 28, 2026$3.92$4.48$3.75$3.890
Aug 31, 2026 – Sep 4, 2026$3.87$4.25$3.60$3.890

Valuation

MetricValueUpside
IC Value
P/E-0.65
P/B0.85
P/S62.24
EV/EBITDA-1.45
PEG
P/TBV0.85

Valuation history

Annual price overlaid with each model's fair value. Y-axis is log scale.

Annual price and model valuations for TAOX, USD per share
YearPriceAIICGraham-DoddGraham Formula
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021$168.75
2022$22.50
2023$4.60
2024$2.90
2025$5.64

Historic valuation ratios

Pick a category, then toggle metrics to compare.

USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About TAO Synergies Inc.

        TAO Synergies Inc. operates as a biopharmaceutical company currently in the clinical development stage. It is dedicated to advancing a bryostatin-1 therapeutic platform, specifically designed to combat Alzheimer's and various other neurodegenerative and cognitive disorders. Beyond its drug development efforts, the firm is also diversifying its treasury strategy, with a new approach centered on the management of digital assets, primarily focusing on the acquisition and 'staking' of TAO cryptocurrency.

        CEO
        Joshua N. Silverman
        Employees
        4
        Beta
        1.43

        Peer comparison

        Same-industry comparables, ranked by market cap.

        Scroll horizontally for additional metrics. Ticker column stays fixed.

        Peer comparison for TAOX: basic info, valuation models, ratios, profitability, leverage, growth, cash flow, dividends, enterprise value, and Altman Z-score.
        Basic InfoIC ValuationCore ValuationProfitabilityLeverage & LiquidityGrowthCash FlowDividendsEnterprise ValueRisk
        TickerCompany NamePriceMarket CapValueUpsideP/EP/BP/SEV/EBITDAPEGP/TBVGross MarginOperating MarginNet MarginROEROICROADebt/EquityInterest CoverageCurrent RatioQuick RatioNet Debt/EBITDAEPS GrowthSales GrowthFCF GrowthFCF YieldOp Cash Flow RatioCash ROICDividend YieldDividend PayoutShareholder YieldEV/EBITEV/FCFEV/SalesAltman Z-Score
        TAOXTAO Synergies Inc.$3.3726.08M-0.650.8562.24-1.450.85100.00%-3025.19%-9609.23%-200.44%-327.75%-131.92%0.0013.993.030.61-19.84%30.94%-34.36%-3.53-231.67%1.41%-0.90%9.09%-1.45-2.0543.86-1.34
        BOLDBoundless Bio, Inc.$2.8964.95M-0.430.250.590.250.00%0.00%0.00%-46.69%-147.34%-32.02%0.508.748.58-0.55-32.47%-25.51%-190.20%-3.72-109.44%0.00%0.00%0.00%0.530.71-2.65
        CVKDCadrenal Therapeutics, In…$1.956.04M-1.115.39-0.815.390.00%0.00%0.00%-260.11%699.75%-183.21%0.002.722.530.30-23.94%71.19%-85.45%-7.94655.33%0.00%0.00%1.98%-0.80-0.85-16.54
        IBIOiBio, Inc.$1.4122.26M$16.19+1,048%-0.480.5922.05-0.221.10100.00%-4650.50%-4594.25%-101.52%-174.01%-70.79%0.24-87.751.591.420.30-73.08%77.78%-18.35%-173.71%-2.51-143.31%0.00%0.00%0.00%-0.20-0.249.36-21.87
        INTSIntensity Therapeutics, I…$4.1611.24M-7.927.74-6.917.740.00%0.00%0.00%-156.90%-4509.23%-122.92%0.015.925.551.02-70.74%-39.34%-10.04%-4.30-3477.59%0.00%0.00%10.18%-6.69-8.6815.11
        NXTCNextCure, Inc.$5.8421.09M-0.651.030.011.030.00%0.00%0.00%-111.23%-10689.42%-85.23%0.154.143.970.39-17.71%20.19%-137.65%-4.70-9204.64%0.00%0.00%0.00%0.010.01-13.74
        RLYBRallybio Corporation$16.1685.76M$48.81+202%-5.960.9262.330.040.9289.28%-3270.86%-1046.39%-15.01%18282.74%-13.77%0.0014.5012.961.12-85.06%34.91%-39.51%-55.75%-7.0619422.15%0.00%0.00%32.63%0.040.04-1.260.29

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $3.89) − 1 = — (IC, example).